辅助人工心臟市场规模、份额、成长分析：按产品类型、按流量类型、按地区 - 产业预测，2024-2031 年

2022年辅助人工心臟的全球市场规模为22亿美元，从2023年的24亿美元成长到2031年的59亿美元，预计预测期内（2024-2031年）复合年增长率为7.9。

心血管疾病的快速增加和心臟移植需求的成长将在未来几年显着推动辅助人工心臟（VAD）的销售。世界人口迅速老化将进一步推动对这种救生设备的需求。新型辅助人工心臟的设计和功能创新，以及研发投资的增加，预计将为该领域的公司创造新的商机。此外，全球医疗保健支出的成长可能会提高辅助人工心臟製造商的盈利。全人工心臟的接受度和可用性的提高也可能支持预测期内及以后的市场扩张。然而，辅助人工心臟的高成本、与其使用相关的潜在併发症以及严格的监管环境等挑战可能会抑制长期的需求前景。总体而言，市场看到了由人口趋势和技术进步推动的强劲成长机会，但相关人员必须克服财务和监管障碍才能充分利用这些机会。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• 案例研究分析
• PESTEL分析
• 总体经济指标
• 贸易分析
• Start-Ups分析
• 原料分析
• 供应链分析
• 价格分析

辅助人工心臟市场：依产品

• 左心室辅助装置
• 右心室辅助装置
• 双心室辅助装置
• 全人工心臟

辅助人工心臟市场：依流程类型

• 脉动流
• 连续流

辅助人工心臟市场：依应用分类

• 通往心臟移植的桥樑
• DT治疗
• 其他的

辅助人工心臟市场：设计

• 市场概况：植入式辅助人工心臟
• 经皮心室辅助装置

辅助人工心臟市场：按地区

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 阿拉伯联合大公国国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• FineHeart SA
• TELEFLEX INCORPORATED
• BiVACOR
• Abbott
• Berlin Heart
• Cardiac Assist, Inc.
• Jarvik Heart, Inc.
• ReliantHeart, Inc.
• SYNCARDIA SYSTEMS
• FRESENIUS MEDICAL CARE AG & CO. KGAA
• GETINGE
• SENKO MEDICAL INSTRUMENT MFG. CO., LTD
• ANGIODROID
• CARDIODYME
• WORLD HEART CORPORATION
• Sun Medical Technology Research Corporation
• CorWave SA
• Windmill Cardiovascular Systems
• Leviticus Cardio
• CardioBridge GmbH

结论和建议

Global Ventricular Assist Devices Market size was valued at USD 2.2 billion in 2022 and is poised to grow from USD 2.4 billion in 2023 to USD 5.9 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

The booming incidence of cardiovascular diseases, coupled with an escalating need for heart transplants, is set to significantly drive the sales of ventricular assist devices (VADs) in the coming years. The rapidly aging global population will further propel the demand for these life-saving devices. Innovations in the design and functionality of new VADs, alongside increased investments in research and development, are expected to unlock fresh opportunities for companies within this sector. Additionally, rising healthcare expenditures worldwide are likely to enhance revenue potential for VAD manufacturers. The growing acceptance and availability of total artificial hearts will also support market expansion throughout the forecast period and beyond. However, challenges such as the high cost of VADs, potential complications associated with their use, and a stringent regulatory landscape may temper the demand outlook in the long run. Overall, while the market presents robust growth prospects driven by demographic trends and technological advancements, stakeholders must navigate financial and regulatory hurdles to fully capitalize on these opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ventricular Assist Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ventricular Assist Devices Market Segmental Analysis

Global Ventricular Assist Devices Market is segmented by Product, Type of Flow, Design, Application, and region. Based on Product, the market is segmented into Left Ventricular Assist Device, Right Ventricular Assist Device, Bi-Ventricular Assist Device, Total Artificial Heart. Based on Type of Flow, the market is segmented into Pulsatile Flow, Continuous Flow. Based on Design, the market is Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device. Based on Application, the market is segmented into Bridge to Transplant, Destination Therapy, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Ventricular Assist Devices Market

The Global Ventricular Assist Devices market is significantly driven by the growing acceptance and awareness surrounding these devices in recent years. As patients increasingly recognize the advantages that ventricular assist devices offer, their willingness to embrace these innovative solutions for heart support is rising. This shift in perception is anticipated to contribute to robust market growth, as more individuals consider these devices as viable options to enhance their treatment outcomes and overall quality of life. Consequently, the demand for ventricular assist devices is expected to continue its upward trajectory, fueled by both medical advancements and patient education.

Restraints in the Global Ventricular Assist Devices Market

The Global Ventricular Assist Devices market faces significant restraints primarily due to limited access in developing regions. These sophisticated medical devices are typically utilized in intricate procedures like heart transplants or the implementation of artificial hearts. However, many developing countries lack the infrastructure and resources to offer such advanced treatments, which restricts the market's potential for growth and sales in these areas. As a result, the inability to provide adequate healthcare options hinders the widespread adoption and distribution of ventricular assist devices, ultimately impacting the overall market dynamics and opportunities for manufacturers and healthcare providers.

Market Trends of the Global Ventricular Assist Devices Market

The global ventricular assist devices market is witnessing a significant trend towards miniaturization, driven by the need for improved implantation versatility and patient outcomes. Companies are increasingly adopting innovative design technologies and materials to create smaller, more efficient devices. This shift not only enhances usability in a broader range of patient anatomies but also aligns with the growing demand for less invasive surgical options. As market players focus on developing compact solutions, enhanced portability and minimized complications are expected to boost sales and market share, positioning these companies favorably in an increasingly competitive landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Supply Chain Analysis
• Pricing Analysis

Global Ventricular Assist Devices Market Size by Product & CAGR (2024-2031)

• Left Ventricular Assist Device
• Right Ventricular Assist Device
• Bi-Ventricular Assist Device
• Total Artificial Heart

Global Ventricular Assist Devices Market Size by Type of Flow & CAGR (2024-2031)

• Pulsatile Flow
• Continuous Flow

Global Ventricular Assist Devices Market Size by Application & CAGR (2024-2031)

• Bridge to Transplant
• Destination Therapy
• Others

Global Ventricular Assist Devices Market Size by Design & CAGR (2024-2031)

• Market Overview Implantable Ventricular Assist Device
• Transcutaneous Ventricular Assist Device

Global Ventricular Assist Devices Market Size & CAGR (2024-2031)

• North America, (Product, Type of Flow, Application, Design)
  • US
  • Canada
• Europe, (Product, Type of Flow, Application, Design)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Type of Flow, Application, Design)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Type of Flow, Application, Design)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Type of Flow, Application, Design)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• FineHeart SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TELEFLEX INCORPORATED
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Assist, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReliantHeart, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYNCARDIA SYSTEMS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FRESENIUS MEDICAL CARE AG & CO. KGAA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GETINGE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SENKO MEDICAL INSTRUMENT MFG. CO., LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANGIODROID
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARDIODYME
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WORLD HEART CORPORATION
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Medical Technology Research Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorWave SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Windmill Cardiovascular Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leviticus Cardio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioBridge GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation